Ani Pharmaceuticals ANIP
NASDAQ ANIP
$67.79 +0.38 (+0.56%)
At close: Nov 9, 2026 · 4:00 PM EST

Ani Pharmaceuticals (ANIP) Return on Capital Employed [ROCE] (2012 - 2026)

Updated

Ani Pharmaceuticals' Return on Capital Employed [ROCE] was 12.80% in Q2 2026, up 11.40 percentage points from 1.41% a year earlier and up 2.42 percentage points from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Return on Capital Employed [ROCE] (2012 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Ani Pharmaceuticals came in at 10.25%, up 10.18 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of +14.46 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was 0.06% in FY2024 (-6.77 pp), 6.84% in FY2023 (+12.13 pp), -5.29% in FY2022 (+2.23 pp) and -7.52% in FY2021 (-3.31 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] since Q2 2019.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has increased for four straight quarters, with an average year-over-year change of +1.70 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2023 (a gain of 14.85 percentage points); the worst was Q1 2022 (a drop of 7.79 percentage points).
  • Per Business Quant data, ANIP's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was 10.39% (Q1 2026), 9.69% (Q4 2025) and 6.51% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 43.74%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 17.52%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 21.60%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 5.33%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 9.91%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 17.37%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -6.15%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 11.32%
10 Ani Pharmaceuticals 1.43 Bn 212.92 Mn 165.89 Mn 12.80%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.80%
Mar 31, 2026 10.39%
Dec 31, 2025 9.69%
Sep 30, 2025 6.51%
Jun 30, 2025 1.41%
Mar 31, 2025 0.60%
Dec 31, 2024 0.05%
Sep 30, 2024 1.28%
Jun 30, 2024 6.45%
Mar 31, 2024 7.43%
Dec 31, 2023 6.25%
Sep 30, 2023 5.68%
Jun 30, 2023 2.77%
Mar 31, 2023 -0.97%
Dec 31, 2022 -5.43%
Sep 30, 2022 -9.17%
Jun 30, 2022 -9.11%
Mar 31, 2022 -9.14%
Dec 31, 2021 -7.46%
Sep 30, 2021 -4.03%
API Access

Ani Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ANIP&period=max&api_key=YOUR_API_KEY